Your browser doesn't support javascript.
loading
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2.
Samelson, Avi J; Tran, Quang Dinh; Robinot, Rémy; Carrau, Lucia; Rezelj, Veronica V; Kain, Alice Mac; Chen, Merissa; Ramadoss, Gokul N; Guo, Xiaoyan; Lim, Shion A; Lui, Irene; Nuñez, James K; Rockwood, Sarah J; Wang, Jianhui; Liu, Na; Carlson-Stevermer, Jared; Oki, Jennifer; Maures, Travis; Holden, Kevin; Weissman, Jonathan S; Wells, James A; Conklin, Bruce R; TenOever, Benjamin R; Chakrabarti, Lisa A; Vignuzzi, Marco; Tian, Ruilin; Kampmann, Martin.
Affiliation
  • Samelson AJ; Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA, USA.
  • Tran QD; Chan-Zuckerberg Biohub, San Francisco, CA, USA.
  • Robinot R; Viral Populations and Pathogenesis Unit, Institut Pasteur, Paris, France.
  • Carrau L; École Doctorale BioSPC, Université de Paris, Sorbonne Paris Cité, Paris, France.
  • Rezelj VV; Institut Pasteur, CIVIC Group, Virus and Immunity Unit, Université de Paris, Paris, France.
  • Kain AM; Microbiology Department, NYU-Langone, New York, NY, USA.
  • Chen M; Viral Populations and Pathogenesis Unit, Institut Pasteur, Paris, France.
  • Ramadoss GN; Viral Populations and Pathogenesis Unit, Institut Pasteur, Paris, France.
  • Guo X; École Doctorale BioSPC, Université de Paris, Sorbonne Paris Cité, Paris, France.
  • Lim SA; Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA, USA.
  • Lui I; Chan-Zuckerberg Biohub, San Francisco, CA, USA.
  • Nuñez JK; Gladstone Institutes, San Francisco, CA, USA.
  • Rockwood SJ; Biomedical Sciences PhD Program, University of California San Francisco, San Francisco, CA, USA.
  • Wang J; Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA, USA.
  • Liu N; Chan-Zuckerberg Biohub, San Francisco, CA, USA.
  • Carlson-Stevermer J; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.
  • Oki J; Department of Antibody Engineering, Genentech Inc., San Francisco, CA, USA.
  • Maures T; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.
  • Holden K; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.
  • Weissman JS; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA.
  • Wells JA; Gladstone Institutes, San Francisco, CA, USA.
  • Conklin BR; School of Medicine, Southern University of Science and Technology, Shenzhen, China.
  • TenOever BR; School of Medicine, Southern University of Science and Technology, Shenzhen, China.
  • Chakrabarti LA; Synthego Corporation, Redwood City, CA, USA.
  • Vignuzzi M; Synthego Corporation, Redwood City, CA, USA.
  • Tian R; Synthego Corporation, Redwood City, CA, USA.
  • Kampmann M; Synthego Corporation, Redwood City, CA, USA.
Nat Cell Biol ; 24(1): 24-34, 2022 01.
Article in En | MEDLINE | ID: mdl-35027731
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Transcription Factors / Epithelial Cells / Angiotensin-Converting Enzyme 2 / SARS-CoV-2 Limits: Humans Language: En Journal: Nat Cell Biol Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Transcription Factors / Epithelial Cells / Angiotensin-Converting Enzyme 2 / SARS-CoV-2 Limits: Humans Language: En Journal: Nat Cell Biol Year: 2022 Document type: Article Affiliation country: Country of publication: